Login / Signup

Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic : Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance.

Michael OertelK ElsayadR Engenhart-CabillicG ReinartzC BauesH SchmidbergerD VordermarkS MarnitzP LukasC RuebeA EngertG LenzH T Eich
Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2020)
RT for hemato-oncological patients receives high-priority and should be maintained even in later stages of the pandemic. Hypofractionation and shortened treatment schedules are feasible options for well-defined constellations, but have to be discussed in the clinical context.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • coronavirus disease
  • sars cov
  • rectal cancer
  • clinical practice
  • robot assisted
  • radiation induced